Issue 2/2004
Content (15 Articles)
Duration of chemotherapy in low-versus high-volume metastatic cancer: Should there be a difference?
Maurie Markman
New antiangiogenic agents for renal cell carcinoma: Bevacizumab
Ronald M. Bukowski
New antiangiogenic agents for renal cell carcinoma: Interferon alfa and thalidomide
Ronald M. Bukowski
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents
Yun Dai, Steven Grant
Assessment of swallowing function in patients with head and neck cancer
Alfred A. Simental Jr, Ricardo L. Carrau